SCHEMBL31730904

SCHEMBL31730904

Cn1c(-c2ccncc2)nc2c(N3CCOCC3)nc(-n3ccc(-c4cccc(F)c4)n3)nc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 12/20 0.42
▸ HSD17B10 Q99714 12/20 0.42
▸ GAA P10253 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ GRIA1 P42261 1/20 0.40
▸ ALDH1A1 P00352 11/20 0.39
▸ HPGD P15428 11/20 0.39
▸ CYP3A4 P08684 5/20 0.39
▸ TSHR P16473 2/20 0.38
▸ STK4 Q13043 1/20 0.37
▸ STK3 Q13188 1/20 0.37
▸ LRRK2 Q5S007 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ CFTR P13569 1/20 0.36
▸ CASP1 P29466 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ CSNK1D P48730 2/20 0.36
▸ PDE10A Q9Y233 1/20 0.35
▸ MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25733566 1.00 KDM4E (0.42) KDM4EHSD17B10GAAMAPK1GRIA1
SCHEMBL30254819 0.90 KDM4E (0.46) KDM4EHSD17B10ALDH1A1HPGDCYP3A4
SCHEMBL25737761 0.90 KDM4E (0.46) KDM4EHSD17B10ALDH1A1HPGDCYP3A4
SCHEMBL31731027 0.90 ROCK2 (0.41) KDM4EHSD17B10ALDH1A1HPGDCYP3A4
SCHEMBL25733561 0.90 ROCK2 (0.41) KDM4EHSD17B10ALDH1A1HPGDCYP3A4
SCHEMBL25275428 0.87 HDAC1 (0.43) KDM4EHSD17B10ALDH1A1HPGDCYP3A4
SCHEMBL30439891 0.87 HDAC1 (0.43) KDM4EHSD17B10ALDH1A1HPGDCYP3A4
SCHEMBL30902946 0.85 PDE10A (0.40) KDM4EHSD17B10ALDH1A1HPGDCYP3A4
SCHEMBL25733565 0.85 PDE10A (0.40) KDM4EHSD17B10ALDH1A1HPGDCYP3A4
SCHEMBL25235923 0.85 PIK3CA (0.38) KDM4EHSD17B10GAAGRIA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250353851-A1 PURINES AND METHODS OF THEIR USE KINETA INC (US) 2025-11-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250353851-A1 PURINES AND METHODS OF THEIR USE TDP1, TDP2, PIKFYVE KDM4E 870/4885HSD17B10 4278/4885GAA 745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback